Aerie Pharma (AERI) Misses Q4 EPS by 12c

Aerie Pharma (NASDAQ: AERI) reported Q4 EPS of ($0.58), $0.12 worse than the analyst estimate of ($0.46).

For earnings history and earnings-related data on Aerie Pharma (AERI) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Keefe, Bruyette & Woods Downgrades Crescent BDC (CCAP) to Market Perform
• Deutsche Bank Upgrades PennyMac Mortgage Investment Trust (PMT) to Buy